Header Logo

Martin Hertl

Concepts (293)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
27
2018
93
4.680
Why?
Liver
11
2019
144
2.020
Why?
Kidney Transplantation
10
2021
120
1.910
Why?
Living Donors
10
2011
15
1.430
Why?
Portal Vein
7
2018
43
1.320
Why?
Hepatectomy
7
2018
58
1.230
Why?
Carcinoma, Hepatocellular
6
2021
26
1.200
Why?
Liver Neoplasms
6
2021
93
1.120
Why?
Liver Failure, Acute
4
2018
5
0.780
Why?
Pancreatitis
1
2021
20
0.770
Why?
Gallstones
1
2021
9
0.770
Why?
Hepatomegaly
1
2018
7
0.630
Why?
Humans
53
2022
25692
0.620
Why?
Kidney Failure, Chronic
7
2020
148
0.560
Why?
Liver Regeneration
4
2017
24
0.550
Why?
Tissue Donors
2
2009
61
0.520
Why?
Middle Aged
28
2020
8403
0.500
Why?
Retrospective Studies
15
2022
3220
0.480
Why?
Swine
7
2018
71
0.460
Why?
Male
34
2021
13917
0.440
Why?
Bile Ducts
2
2011
11
0.430
Why?
BK Virus
1
2013
11
0.420
Why?
Constriction, Pathologic
2
2019
31
0.420
Why?
Carcinoma, Transitional Cell
1
2013
16
0.420
Why?
Organ Preservation
2
2011
6
0.410
Why?
Perfusion
2
2011
12
0.410
Why?
Kidney Neoplasms
1
2013
70
0.400
Why?
Hypertension, Malignant
1
2012
1
0.390
Why?
Protein S Deficiency
1
2011
2
0.390
Why?
Female
27
2021
14273
0.390
Why?
Galactosyltransferases
2
2013
2
0.380
Why?
Hypercholesterolemia
1
2011
26
0.380
Why?
Arteriovenous Shunt, Surgical
2
2022
23
0.370
Why?
Mesentery
1
2011
5
0.370
Why?
Carcinoid Tumor
1
2011
5
0.370
Why?
Ligation
4
2018
33
0.370
Why?
Peritoneal Neoplasms
1
2011
7
0.370
Why?
Kidney
4
2021
155
0.360
Why?
Animals
11
2021
3510
0.350
Why?
Intestines
1
2011
88
0.350
Why?
Decision Support Techniques
1
2010
46
0.350
Why?
Endothelial Cells
1
2010
57
0.340
Why?
Postoperative Complications
9
2022
827
0.340
Why?
Adrenal Cortex Neoplasms
2
2020
12
0.340
Why?
Adrenocortical Carcinoma
2
2020
14
0.330
Why?
Food Hypersensitivity
1
2009
40
0.320
Why?
Treatment Outcome
15
2022
3231
0.310
Why?
Bile Duct Neoplasms
2
2005
5
0.310
Why?
Hepatopulmonary Syndrome
1
2008
1
0.300
Why?
Hepatitis C
2
2008
44
0.300
Why?
Neuroendocrine Tumors
2
2019
45
0.300
Why?
Gastrointestinal Stromal Tumors
1
2008
25
0.300
Why?
Informed Consent
2
2005
21
0.290
Why?
Tissue and Organ Harvesting
3
2004
19
0.290
Why?
Biliary Tract Diseases
2
2019
6
0.270
Why?
Tissue and Organ Procurement
2
2003
24
0.270
Why?
Coccidioides
1
2006
1
0.260
Why?
Coccidioidomycosis
1
2006
6
0.260
Why?
Registries
1
2007
170
0.260
Why?
Transplantation, Heterologous
2
2016
17
0.250
Why?
Liver Diseases
2
2017
32
0.250
Why?
Directed Tissue Donation
1
2005
1
0.240
Why?
Donor Selection
1
2005
1
0.240
Why?
Neoplasm Staging
3
2018
315
0.240
Why?
Physician-Patient Relations
1
2005
37
0.230
Why?
Survival Rate
5
2020
308
0.230
Why?
Adult
13
2020
7336
0.230
Why?
Cholangiopancreatography, Endoscopic Retrograde
2
2021
9
0.230
Why?
Hepatitis B, Chronic
1
2003
4
0.220
Why?
Postoperative Hemorrhage
2
2014
24
0.220
Why?
Biliary Tract Surgical Procedures
2
2019
4
0.220
Why?
Communication
1
2005
119
0.220
Why?
Incidence
3
2021
731
0.220
Why?
Venous Thrombosis
2
2019
42
0.210
Why?
Liver Failure
2
2018
10
0.200
Why?
Time Factors
6
2022
1336
0.200
Why?
Aneurysm
1
2022
10
0.200
Why?
Gastroparesis
1
2022
2
0.200
Why?
Arteriovenous Fistula
1
2022
12
0.200
Why?
Pancreaticoduodenectomy
1
2022
15
0.200
Why?
Urogenital Abnormalities
1
2021
7
0.190
Why?
Hospitals, University
1
2001
25
0.190
Why?
Infertility, Female
1
2021
11
0.190
Why?
Specialization
1
2001
16
0.190
Why?
Cholecystectomy
1
2021
19
0.190
Why?
Organ Transplantation
1
2021
22
0.190
Why?
Immunoglobulin G
2
2013
92
0.190
Why?
Follow-Up Studies
5
2020
1689
0.190
Why?
Antineoplastic Agents
2
2021
169
0.190
Why?
Organ Size
2
2018
103
0.190
Why?
Random Allocation
2
2018
116
0.190
Why?
Xenograft Model Antitumor Assays
1
2021
24
0.190
Why?
Transplant Recipients
1
2021
20
0.190
Why?
Bone Marrow Transplantation
2
2013
22
0.190
Why?
Pancreas
1
2021
29
0.190
Why?
Pancreatic Neoplasms
2
2019
89
0.180
Why?
Renal Dialysis
4
2022
115
0.180
Why?
Surgical Instruments
1
2020
18
0.180
Why?
Prognosis
4
2020
739
0.180
Why?
Gene Expression Regulation, Neoplastic
1
2021
92
0.180
Why?
Ultrasonography
3
2018
235
0.180
Why?
Hepatic Veins
2
2018
9
0.170
Why?
Health Care Costs
1
2020
75
0.170
Why?
Graft Survival
7
2016
92
0.170
Why?
Margins of Excision
1
2020
20
0.170
Why?
Adrenalectomy
1
2019
4
0.170
Why?
Jejunostomy
1
2019
8
0.170
Why?
Suture Techniques
1
2020
136
0.170
Why?
Chemotherapy, Adjuvant
1
2019
69
0.170
Why?
Hospitalization
1
2021
292
0.160
Why?
Patient Compliance
1
2020
148
0.160
Why?
Abdominal Neoplasms
1
2019
14
0.160
Why?
Heat Stroke
1
2018
1
0.160
Why?
Intestinal Neoplasms
1
2018
10
0.160
Why?
Digestive System Surgical Procedures
1
2018
22
0.150
Why?
Child, Preschool
2
2013
640
0.150
Why?
Venous Thromboembolism
1
2019
30
0.150
Why?
Stomach Neoplasms
1
2018
32
0.150
Why?
Papio
3
2016
6
0.150
Why?
Pulmonary Embolism
1
2019
55
0.150
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
53
0.150
Why?
Neovascularization, Physiologic
1
2017
19
0.140
Why?
Hypertrophy
1
2017
23
0.140
Why?
Vascular Patency
4
2022
17
0.140
Why?
Aged
10
2020
8501
0.130
Why?
Prostatic Neoplasms
1
2017
97
0.130
Why?
Liver Cirrhosis
2
2014
37
0.130
Why?
Disease Models, Animal
1
2018
584
0.130
Why?
Graft Occlusion, Vascular
2
2022
19
0.130
Why?
Liver Function Tests
2
2015
19
0.130
Why?
Tobacco Use Disorder
1
2015
16
0.120
Why?
Jaundice, Obstructive
1
2015
1
0.120
Why?
Biopsy
2
2013
199
0.120
Why?
Cysts
1
2015
16
0.120
Why?
Graft Rejection
4
2020
63
0.120
Why?
Antibodies, Heterophile
1
2013
1
0.110
Why?
Papio hamadryas
1
2013
1
0.110
Why?
Swine, Miniature
1
2013
5
0.110
Why?
Heterografts
1
2013
12
0.110
Why?
Heart-Assist Devices
1
2014
16
0.110
Why?
Heart Transplantation
1
2014
29
0.110
Why?
Bilirubin
2
2011
11
0.110
Why?
Creatinine
1
2013
47
0.110
Why?
Hypoxia
2
2017
35
0.110
Why?
Hematoma
1
2013
18
0.110
Why?
Magnetic Resonance Imaging
3
2015
1084
0.110
Why?
Ureterostomy
1
2012
1
0.100
Why?
Polytetrafluoroethylene
2
2011
5
0.100
Why?
Cystostomy
1
2012
5
0.100
Why?
Blood Vessel Prosthesis
2
2011
12
0.100
Why?
Databases, Factual
3
2019
329
0.100
Why?
Ureter
1
2012
26
0.100
Why?
Hepatic Encephalopathy
1
2012
3
0.100
Why?
Protein S
1
2011
1
0.100
Why?
Neoplasm Metastasis
2
2018
91
0.100
Why?
Patient Selection
3
2015
170
0.100
Why?
Intracranial Pressure
1
2012
12
0.100
Why?
Warm Ischemia
1
2011
2
0.100
Why?
Bile
1
2011
5
0.100
Why?
Intracranial Hypertension
1
2012
14
0.100
Why?
Monitoring, Intraoperative
1
2012
33
0.100
Why?
Alkaline Phosphatase
1
2011
19
0.100
Why?
Hepatitis, Autoimmune
1
2011
5
0.100
Why?
Hemodynamics
1
2011
57
0.100
Why?
Energy Metabolism
1
2011
47
0.090
Why?
Oxygen
1
2011
74
0.090
Why?
Endoscopy, Digestive System
1
2011
8
0.090
Why?
Tomography, X-Ray Computed
2
2015
698
0.090
Why?
Gastrointestinal Hemorrhage
1
2011
16
0.090
Why?
Waiting Lists
2
2014
16
0.090
Why?
Intestinal Obstruction
1
2011
11
0.090
Why?
Complement C3a
1
2010
1
0.090
Why?
End Stage Liver Disease
1
2010
13
0.090
Why?
Transplantation, Autologous
1
2011
151
0.090
Why?
Complement Activation
1
2010
10
0.090
Why?
Cytotoxicity, Immunologic
1
2010
16
0.090
Why?
Immunoglobulin M
1
2010
14
0.090
Why?
Tissue Engineering
1
2010
30
0.090
Why?
Kaplan-Meier Estimate
1
2010
157
0.090
Why?
Risk Factors
3
2022
2224
0.080
Why?
Young Adult
2
2020
1855
0.080
Why?
Fatal Outcome
1
2009
51
0.080
Why?
Anaphylaxis
1
2009
9
0.080
Why?
Survival Analysis
3
2018
246
0.080
Why?
Neoplasm Recurrence, Local
1
2010
198
0.080
Why?
Nephrectomy
1
2009
35
0.080
Why?
Hemophilia A
1
2008
41
0.080
Why?
Transplantation Chimera
1
2008
1
0.070
Why?
Transplantation Tolerance
1
2008
2
0.070
Why?
Cadaver
1
2009
349
0.070
Why?
Multivariate Analysis
2
2019
299
0.070
Why?
Reoperation
1
2012
818
0.070
Why?
Colonoscopy
1
2008
62
0.070
Why?
Immunosuppressive Agents
2
2020
124
0.070
Why?
Rats, Wistar
2
2017
49
0.070
Why?
New England
1
2006
3
0.070
Why?
Cholangitis, Sclerosing
1
2006
3
0.060
Why?
Hepatoblastoma
1
2005
1
0.060
Why?
Cholangiocarcinoma
1
2005
3
0.060
Why?
Blood Coagulation Factors
2
2016
19
0.060
Why?
Hemangioendothelioma, Epithelioid
1
2005
5
0.060
Why?
Cystic Duct
1
2005
1
0.060
Why?
Coercion
1
2005
5
0.060
Why?
Cholestasis
1
2005
10
0.060
Why?
Social Values
1
2005
9
0.060
Why?
Postoperative Period
2
2019
292
0.060
Why?
Interview, Psychological
1
2005
41
0.060
Why?
Medical Oncology
1
2005
35
0.060
Why?
Liver Circulation
2
2017
6
0.060
Why?
Animals, Genetically Modified
2
2014
18
0.060
Why?
Combined Modality Therapy
2
2019
281
0.060
Why?
Contrast Media
1
2004
68
0.060
Why?
Referral and Consultation
1
2005
86
0.060
Why?
Adenoma
1
2005
56
0.060
Why?
Anastomosis, Surgical
2
2019
30
0.050
Why?
United States
2
2020
1943
0.050
Why?
Decision Making
1
2005
203
0.050
Why?
Pancreatic Fistula
1
2022
3
0.050
Why?
Strategic Planning
1
2021
7
0.050
Why?
Steroids
1
2022
23
0.050
Why?
Rats
2
2016
649
0.050
Why?
Uterus
1
2021
14
0.050
Why?
Hysterectomy
1
2021
22
0.050
Why?
Naphthoquinones
1
2021
5
0.050
Why?
Benzofurans
1
2021
6
0.050
Why?
Aniline Compounds
1
2021
31
0.050
Why?
Sulfonamides
1
2021
40
0.050
Why?
Cost Savings
1
2020
36
0.040
Why?
Quality Improvement
1
2022
132
0.040
Why?
Cost-Benefit Analysis
1
2020
124
0.040
Why?
Diagnosis, Differential
2
2013
341
0.040
Why?
Mitotane
1
2019
3
0.040
Why?
Lymphatic Metastasis
1
2020
81
0.040
Why?
Disease-Free Survival
1
2019
152
0.040
Why?
Blood Coagulation Disorders
1
2019
16
0.040
Why?
Serum Albumin
1
2019
19
0.040
Why?
Adolescent
2
2020
2076
0.040
Why?
Operative Time
1
2019
83
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
222
0.040
Why?
Anticoagulants
1
2019
88
0.040
Why?
Dose-Response Relationship, Drug
1
2018
325
0.040
Why?
Prostate-Specific Antigen
1
2017
15
0.040
Why?
Portal Pressure
1
2017
5
0.040
Why?
Hyperplasia
1
2017
17
0.030
Why?
Mice
1
2021
1345
0.030
Why?
Brain
1
2006
1560
0.030
Why?
Cell Hypoxia
1
2016
11
0.030
Why?
Models, Animal
1
2016
110
0.030
Why?
Policy
1
2015
7
0.030
Why?
Chicago
1
2018
869
0.030
Why?
Smoking Cessation
1
2015
41
0.030
Why?
Risk Assessment
1
2017
618
0.030
Why?
Cardiovascular Diseases
1
2018
340
0.030
Why?
Stents
1
2015
80
0.030
Why?
Thrombocytopenia
1
2014
20
0.030
Why?
Smoking
1
2015
165
0.030
Why?
Blood Transfusion
1
2014
56
0.030
Why?
Attitude of Health Personnel
1
2015
146
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2013
4
0.030
Why?
Gene Knockout Techniques
1
2013
4
0.030
Why?
Immunity, Cellular
1
2013
29
0.030
Why?
Cohort Studies
1
2018
1781
0.030
Why?
Biomarkers
1
2014
554
0.020
Why?
Aged, 80 and over
1
2020
4459
0.020
Why?
Biocompatible Materials
1
2011
88
0.020
Why?
Surveys and Questionnaires
1
2015
1077
0.020
Why?
Hepatocytes
1
2010
11
0.020
Why?
Extracellular Matrix
1
2010
49
0.020
Why?
Angiography
1
2009
29
0.020
Why?
Factor VIII
1
2008
26
0.020
Why?
Blood Loss, Surgical
1
2008
52
0.020
Why?
Hemorrhage
1
2008
75
0.020
Why?
Hepatitis C, Chronic
1
2008
37
0.020
Why?
Hepatocyte Nuclear Factor 3-alpha
1
2008
1
0.020
Why?
Histocompatibility Testing
1
2008
2
0.020
Why?
Transplantation Immunology
1
2008
3
0.020
Why?
Granzymes
1
2008
5
0.020
Why?
Transplantation Conditioning
1
2008
31
0.020
Why?
T-Lymphocytes
1
2008
88
0.020
Why?
Laparoscopy
1
2009
170
0.020
Why?
RNA, Messenger
1
2008
284
0.020
Why?
Transplantation, Homologous
1
2008
248
0.020
Why?
Prospective Studies
1
2011
1633
0.020
Why?
Vena Cava, Inferior
1
2006
10
0.020
Why?
Syndrome
1
2005
69
0.010
Why?
Biliary Tract
1
2004
3
0.010
Why?
Cholangiopancreatography, Magnetic Resonance
1
2004
4
0.010
Why?
Hepatic Artery
1
2004
3
0.010
Why?
Magnetic Resonance Angiography
1
2004
28
0.010
Why?
Preoperative Care
1
2004
116
0.010
Why?
Imaging, Three-Dimensional
1
2004
217
0.010
Why?
Liver Cirrhosis, Alcoholic
1
2002
4
0.010
Why?
Forecasting
1
2001
92
0.010
Why?
Hertl's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (293)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_